AbbVie Inc. (NYSE: ABBV)
Drug Manufacturers - General · North Chicago, IL, United States · Founded 2013
- Market capitalization: $310.0 billion
- Annual revenue: $61.16 billion
- Net income: $4.23 billion
- Employees: 50,000
- Sector: Healthcare
- Headquarters: North Chicago, United States
- Founded: 2013
Source: Statvoo company profile for AbbVie Inc.. Browse all 500+ companies
AbbVie is a biopharmaceutical company best known for Humira, which was the best-selling drug in history before losing patent exclusivity. The company has pivoted to Skyrizi and Rinvoq (immunology), plus a growing oncology and neuroscience portfolio. AbbVie was spun off from Abbott Laboratories in 2013 and has since become one of the largest pharma companies globally with over $54 billion in annual revenue.
Branded prescription drug sales are the entire game. Skyrizi and Rinvoq are ramping fast to replace Humira's lost revenue. AbbVie also generates significant revenue from Botox and other aesthetics products following the $63 billion Allergan acquisition. R&D spending exceeds $7 billion annually.
Spun off from Abbott Laboratories on January 1, 2013. Humira became the world's best-selling drug, peaking at over $21 billion in annual sales. The $63 billion Allergan acquisition in 2020 added Botox and diversified the portfolio. Humira biosimilar competition began in earnest in 2023, triggering the company's biggest strategic challenge.
| Market Capitalization | $310.0B |
| Annual Revenue | $61.16B |
| Net Income | $4.23B |
| Profit Margin | 7% |
| Revenue per Employee | $1223200K |
| Stock Exchange | NYSE |
| Ticker Symbol | ABBV |
Financial data is approximate and based on most recent annual filings.
Humira generated over $200 billion in cumulative sales during its lifetime u2014 more than any drug in pharmaceutical history. AbbVie built a "patent thicket" of over 100 patents around Humira to delay biosimilar competition for years. Botox, originally a treatment for eye spasms, now generates over $5 billion annually across cosmetic and therapeutic uses.
The Humira cliff was supposed to be catastrophic, but Skyrizi and Rinvoq are absorbing the blow better than expected u2014 AbbVie's pipeline execution has been genuinely impressive.
What is AbbVie Inc.'s revenue?
AbbVie Inc. generates approximately $61.16 billion in annual revenue.
How many employees does AbbVie Inc. have?
AbbVie Inc. employs approximately 50,000 people worldwide.
What is AbbVie Inc.'s market cap?
AbbVie Inc. (ABBV) has a market capitalization of approximately $310.0 billion on the NYSE.
When was AbbVie Inc. founded?
AbbVie Inc. was founded in 2013 and is headquartered in North Chicago, IL, United States.
Who is the CEO of AbbVie Inc.?
Robert Michael is the current CEO of AbbVie Inc..
What is AbbVie Inc.'s website?
AbbVie Inc.'s official website is abbvie.com.
| CEO | Robert Michael |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Founded | 2013 |
| HQ | North Chicago, IL |
| Country | United States |
| Website | abbvie.com |
See traffic, security, and technical data for AbbVie Inc.'s website:
📊 abbvie.com stats 📋 WHOIS 🌐 DNS 🔒 SSL